Biotech · Private company
Rovi Pharmaceuticals Laboratories
Track this companyFree. Adds Rovi Pharmaceuticals Laboratories to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Risperidone ISM 100 mgPhase 3 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- Risperidone ISM 100 mgPhase 3 · Acute SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- Risperidone ISM 75 mgPhase 3 · Acute SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- Risperidone ISM 75 mgPhase 3 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- EU sourced oral Femara® + Letrozole SIEPhase 1 · Hormone Receptor Positive Early Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Risperdal 4mg TabletPhase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- US-sourced oral Femara® + Letrozole SIEPhase 1 · Hormone Receptor Positive Early Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast CancerPHASE1 · RECRUITING · started Jun 8, 2026ClinicalTrials.gov NCT07401381 · fetched Nov 12, 2026
- Comparative Bioavailability of Risperidone.PHASE1 · COMPLETED · started Mar 9, 2021ClinicalTrials.gov NCT05179525 · fetched Nov 12, 2026
- Comparative Bioavailability of RisperidonePHASE1 · COMPLETED · started Jul 9, 2018ClinicalTrials.gov NCT03527186 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label ExtensionPHASE3 · COMPLETED · started Aug 25, 2017ClinicalTrials.gov NCT03870880 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute SchizophreniaPHASE3 · COMPLETED · started Jun 2, 2017ClinicalTrials.gov NCT03160521 · fetched Nov 12, 2026